Close

Ms Helen Strongman

BA MSc

Research Fellow

Room
250

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

I am an epidemiologist with expertise in using UK electronic health record data for research. Before joining LSHTM in 2017, I worked in the Observational Research team at the Clinical Practice Research Datalink (CPRD) for 6 years. I now use CPRD data to investigate cardiovascular disease risk in cancer survivors. I have a masters in Modern Epidemiology from Imperial College London, an undergraduate degree in Natural Sciences from the University of Cambridge, and a portfolio of previous positions in global pharmaceutical market research agencies and the French Embassy in London.

Affiliations

Faculty of Epidemiology and Population Health
Department of Non-communicable Disease Epidemiology

Teaching

I facilitate Extended Epidemiology and Statistical Methods in Epidemiology MSc practical sessions and am deputy course organiser for the Systematic Reviews short course. I supervise distance learning MSc summer projects.

Research

Research Area
Clinical databases
Primary care
Electronic health records
Discipline
Pharmacoepidemiology
Epidemiology
Disease and Health Conditions
Cancer
Cardiovascular disease
Non-communicable diseases
Country
United Kingdom

Selected Publications

Body mass index and Hodgkin's lymphoma: UK population-based cohort study of 5.8 million individuals.
Strongman H; Brown A; Smeeth L; Bhaskaran K
2019
British journal of cancer
Limitations for health research with restricted data collection from UK primary care.
Strongman H; Williams R; Meeraus W; Murray-Thomas T; Campbell J; Carty L; Dedman D; Gallagher AM; Oyinlola J; Kousoulis A
2019
Pharmacoepidemiology and drug safety
Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review.
Matthews A; Stanway S; Farmer RE; Strongman H; Thomas S; Lyon AR; Smeeth L; Bhaskaran K
2018
BMJ (Clinical research ed)
Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications.
Padmanabhan S; Carty L; Cameron E; Ghosh RE; Williams R; Strongman H
2018
European journal of epidemiology
Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study.
Strongman H; Christopher S; Majak M; Williams R; Bahmanyar S; Linder M; Heintjes EM; Bennett D; Korhonen P; Hoti F
2018
BMJ open diabetes research & care
Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries.
Korhonen P; Heintjes EM; Williams R; Hoti F; Christopher S; Majak M; Kool-Houweling L; Strongman H; Linder M; Dolin P
2016
BMJ (Clinical research ed)
See more Publications